TAG:利用血常规中的血小板和淋巴细胞比值来预测克罗恩病患者疾病活动度

2021-02-21 MedSci原创 MedSci原创

克罗恩病(CD)是一种慢性胃肠道炎症性疾病,其特征是疾病缓解和复发反复交替出现。

      克罗恩病(CD)是一种慢性胃肠道炎症性疾病,其特征是疾病缓解和复发反复交替出现。在克罗恩病确诊的20年内,大约一半的CD患者出现肠并发症,例如狭窄或瘘管的发生。因此,在CD的整个疾病过程中,密切监视疾病活动至关重要。目前,内窥镜愈合被认为是CD的主要治疗目标,因为它可以减少疾病相关并发症,随后的住院治疗和手术风险。然而,内窥镜检查是侵入性的,耗时的且昂贵的,并且被认为是用于CD患者疾病监测的最不可接受的检查。因此,需要精确和可靠的非侵入性的替代标志物,以评估CD内窥镜疾病活动的严重程度。

 

 

      理想的非侵入性诊断标记应简单,易于获取,便宜且准确。最常用的标志物是粪便钙卫蛋白(FC),C反应蛋白(CRP),红细胞沉降率(ESR)等等。CRP水平和ESR是炎症的重要急性期标志物,并已证明在CD患者疾病活动性评估中表现良好。最近的证据证明CD患者的全血细胞计数(CBC)会发生明显异常。许多研究发现,一些常规的CBC血液指标,例如红细胞分布宽度,血小板计数,平均血小板体积和血小板生成比(PCT)可以用作监测CD患者疾病活动的生物标志物。因此,本项研究的目的是建立一个简单的模型来预测患者肠道粘膜愈合情况。

 

 

 

      研究人员对2016年至2020年间的中国四个三级医疗中心接受内镜检查的已确诊CD患者进行了回顾性分析。CD的简单内镜评分,CBC参数,C反应蛋白(CRP)水平,红细胞沉降的个体变量率和粪便钙卫蛋白(FC)由不同的研究者独立进行分析。然后对各个变量和患者内镜下粘膜愈合程度进行相关性分析。

 

 

      本项研究共纳入882名符合条件的CD患者,进行了总共1388次内窥镜检查,有用的常规血液参数和相关指标被研究人员仔细收集。研究人员发现使用血小板与淋巴细胞百分比比值(PLpR)的模型具有较高的识别内镜缓解(ER)患者的准确度,曲线下面积(AUC)为0.785 [95%(CI):0.784–0.787] ,与CRP相当(AUC:0.775,95%CI:0.774-0.777)。值得注意的是,患有结肠疾病且有手术史的患者的PLpR的AUC显着高于CRP。此外,在将FC和PLpR结合后,FC + PLpR的AUC值增加到高达0.892(95%CI:0.890-0.894)来鉴定内镜下粘膜愈合。

 

 

 

      本项研究可根据来自CD患者的CBC的血小板和淋巴细胞百分比(PLpR),来鉴定CD患者的粘膜愈合情况。

 

 

原始出处 :

Rirong Chen. Et al. Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease. Therapeutic Advances in Gastroenterology.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1756108, encodeId=ecae1e5610879, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Fri Dec 17 18:25:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799455, encodeId=563b1e99455a2, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Nov 23 03:25:26 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924401, encodeId=fa70192440161, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sat Jun 26 17:25:26 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302364, encodeId=15a313023647a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Tue Feb 23 07:25:26 CST 2021, time=2021-02-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1756108, encodeId=ecae1e5610879, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Fri Dec 17 18:25:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799455, encodeId=563b1e99455a2, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Nov 23 03:25:26 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924401, encodeId=fa70192440161, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sat Jun 26 17:25:26 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302364, encodeId=15a313023647a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Tue Feb 23 07:25:26 CST 2021, time=2021-02-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1756108, encodeId=ecae1e5610879, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Fri Dec 17 18:25:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799455, encodeId=563b1e99455a2, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Nov 23 03:25:26 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924401, encodeId=fa70192440161, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sat Jun 26 17:25:26 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302364, encodeId=15a313023647a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Tue Feb 23 07:25:26 CST 2021, time=2021-02-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1756108, encodeId=ecae1e5610879, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Fri Dec 17 18:25:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799455, encodeId=563b1e99455a2, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Nov 23 03:25:26 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924401, encodeId=fa70192440161, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Sat Jun 26 17:25:26 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302364, encodeId=15a313023647a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Tue Feb 23 07:25:26 CST 2021, time=2021-02-23, status=1, ipAttribution=)]

相关资讯

Blood:XPR1调控血小板多聚磷酸盐的蓄积抑制血栓形成

多聚磷酸盐是一种线性连接的正磷酸盐残基的促凝的无机聚合物。多项研究已经证实了血小板多聚磷酸盐在凝血中的重要性,然而在哺乳动物中,聚磷酸盐稳态的机制细节在很大程度上尚不清楚。

BMC Gastroenterology: 术前血小板计可以预测肝移植患者移植后门静脉并发症概率

肝移植被认为是晚期肝病患者的唯一治疗选择。在过去的几十年里,肝移植的效果已经随着外科技术的进步,免疫抑制的发展和围手术期护理完善获得大大改善。

Blood:重度COVID-19患者的血小板激活和血小板-单核细胞聚集形成触发组织因子表达

在COVID-19重症患者中,血小板活化和血小板单核细胞聚集形成增加与预后不良有关;重症COVID-19患者的血小板可通过P-选择素和整合素αIIb/β3信号通路诱导单核细胞组织因子表达。

Sci Rep:反复膀胱注射富血小板血浆可改善难治性间质性膀胱炎患者的症状和改变泌尿功能蛋白

反复膀胱注射自体富含血小板的血浆(PRP)可以改善间质性膀胱炎/膀胱疼痛综合征(IC/BPS)患者的症状;然而,该疗法有效性的客观证据依旧缺乏。

Blood:HLA表位抗原错配对输血小板的效果的影响

血小板输注无效会导致不良预后和增加医疗费用。处理由于HLA同种异体免疫引起的难治性,需要使用HLA抗原匹配的血小板,但需要大量的血小板捐献者,并且不能保证完全匹配。

Blood:血小板和iPSC来源的巨核细胞的全基因组转录图谱和RNA测序

GWAS研究已经明确了与血小板相关表型相关的常见变异,但由于这些变异主要位于内含子中或基因间,它们与血小板生物学特征的相关性尚不清楚。